Medindia
Medindia LOGIN REGISTER
Advertisement

Cobalis Creates Retail Marketing and Distribution Division and Launches US Retail Marketing for PreHistin®

Tuesday, July 27, 2010 Corporate News
Advertisement


IRVINE, Calif., July 27 Cobalis Corp. (Pink Sheets: CLSC) announced today that it has entered into a distribution partnership agreement with OTM LIC, Inc. (OTM) to facilitate the creation of retail marketing and distribution division within the Company. OTM will help manage the new division and assist Cobalis in launching its flagship product, PreHistin® Allergy Defense Formula, to national chain pharmacies, mass merchandisers and retailers, and convenience stores.
Advertisement

OTM principals John Legge and Jeff Dole bring more than 40 years of successful executive retail marketing expertise, as well as a significant portfolio of high level contacts and relationships with the country's largest retailers and chain pharmacies.
Advertisement

Based out of Cobalis' new corporate headquarters in Irvine, California, Legge and Dole will spearhead a major national retail marketing program intended to place PreHistin® on retail shelves coast-to-coast by year-end or sooner. OTM will represent PreHistin® to US retail targets, as well as any future products Cobalis may develop or acquire. Legge and Dole will also present PreHistin® at trade shows and expos where retailers preview and place orders for new products.

Under the engagement being announced, Cobalis will also receive 25% of all net revenues OTM generates from all current and future products represented. Thus, Cobalis will derive a considerable revenue stream from sales of several consumer healthcare products OTM presently represents to retailers and convenience stores across the US.

Marty Marion, Cobalis CEO said: "Retail has always been a core priority for marketing PreHistin®. We believe that PreHistin® represents a unique alternative to after-the-fact antihistamines for the 60+ million seasonal and year-round allergy sufferers in the US. Our ability to enable consumers to find PreHistin® on their local pharmacy and retailers' shelves will greatly enhance our ability to establish PreHistin® as a nationally accepted brand. We are very pleased to have created a dedicated retail marketing division, and to have engaged John Legge and Jeff Dole to spearhead our success in achieving this goal as quickly as possible."

OTM President John Legge said: "OTM's strong relationships and expertise in retail marketing will enable us to hit the ground running and obtain substantial sales for PreHistin® in the US retail market. Our initial discussions and presentations have already generated a high level of interest from a number of major national retailers. PreHistin® is a very unique and effective product that we believe will meet with great success at the retail level. We are excited to work with Cobalis and feel that we have established a symbiotic partnership which will generate significant revenues for both parties from several product revenue streams starting immediately."

The engagement of OTM marks a major milestone for Cobalis as the company nears its national online and DRTV launch dates.

ABOUT COBALIS CORP--PREHISTIN®

Cobalis Corp. is a specialty pharmaceutical, nutraceutical and preventive healthcare product development and marketing company. Its flagship product, PreHistin® Allergy Defense Formula, The World's FIRST Pre-Histamine, is designed to mitigate overproduction of IgE levels and restore a normal response to seasonal and year-round indoor and outdoor allergens. PreHistin® is available without prescription for both long-term and daily use.

For PreHistin® product information and ordering please visit at www.PreHistin.com or call toll free 1-877-4POLLEN. For additional company information please visit the corporate website at www.Cobalis.com

CONTACT ------- Cobalis Corp. 16795 Von Karman, Suite 200 Irvine, CA 92606 Chas Radovich and Martin Marion +1-949-260-9007 [email protected]

SOURCE Cobalis Corp.
Sponsored Post and Backlink Submission


Latest Press Release on Corporate News

This site uses cookies to deliver our services.By using our site, you acknowledge that you have read and understand our Cookie Policy, Privacy Policy, and our Terms of Use  Ok, Got it. Close